This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...
CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
WASHINGTON (Reuters) - U.S. regulators are likely to update the public within days about any potential heart risks of AstraZeneca Plc's stomach-acid drugs, which are taken by more than 1 billion ...
WASHINGTON, Dec 10 (Reuters) - U.S. regulators gave a clean bill of health to AstraZeneca Plc's Prilosec and Nexium on Monday, saying they found no evidence of an increased risk of heart problems from ...
Four months after GSK settled a key case in California over its heartburn medication Zantac, AstraZeneca is following suit, agreeing to resolve personal injury claims over its heartburn drugs Nexium ...
WASHINGTON (AP) - The popular heartburn drugs Prilosec and Nexium don't appear to spur heart problems, the Food and Drug Administration announced Thursday. The agency reviewed the issue after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results